Navigation Links
Silymarin does not affect virus activity or ALT levels in
Date:2/1/2008

ological response in only a third to a half of all patients with the predominant form of the infection in the U.S., namely genotype 1, and it can cause unpleasant and sometimes serious side effects. The NIH study, referred to as the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) Trial, was designed, therefore, to treat persons with advanced chronic hepatitis C who had failed previous antiviral therapy with the hope that the long-term treatment would reduce progression of the chronic liver disease even if it did not affect the virus itself. The reason for interviewing enrollees in the trial was to determine the extent of use of alternative therapies in this committed group, since the popularity of herbal products has increased in the U.S., many HCV patients choosing to supplement, or even replace, the standard treatment with herbals. Silymarin (milk thistle extract) has been the most popular option for people with liver disease. Although it is the most frequent product utilized, silymarin has not been rigorously studied using accepted scientific approaches, and therefore such studies are clearly required and warranted.

For the present survey, researchers interviewed all HALT-C participants on past and current use of all prescription and non-prescription drugs, including herbal medications, dietary supplements and other botanical products. Of 1145 study participants, 56 percent said that they had never used herbal products, while 23 percent were using them currently, some 60 different varieties. Silymarin was by far the most common. Usage was higher among men, among non-Hispanic whites, and among the more highly educated. Interestingly, the researchers also found geographic disparities in silymarin usage. It was most popular in Colorado, Michigan and Southern California and least popular in Maryland and Massachusetts.

In comparing the clinical data of silymarin users and non-users, the researchers found that the levels of HCV
'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cutting Salt Wont Affect Foods Safety
2. A childs IQ could be affected by maternal epilepsy
3. Sexual function affected by stem cell transplant according to long-term study
4. Family history of alcoholism affects response to drug used to treat heavy drinking
5. Obesity Wont Affect Seniors Memory
6. Genetic variation affects smoking cessation treatment
7. Schizophrenia candidate genes affect even healthy individuals
8. R rating might be unlikely to affect teens exposure to smoking in movies
9. Painful condition affecting kidney failure patients increases risk of death
10. Patients perceived cancer care unaffected by lower Medicare reimbursements
11. The Current Recall of Boy Scouts of Americas Plastic Badges Does Not Affect Embroidered Insignia, Badges & Awards Produced by Lion Brothers Company Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... The American College of ... management and treatment of pulmonary arterial hypertension (PAH) ... in Adults: CHEST Guideline, in the journal CHEST. ... and provide the latest and most accurate treatment ... Association (PHA) – the country’s leading pulmonary ...
(Date:8/27/2014)... HealthDay Reporter WEDNESDAY, Aug. 27, 2014 (HealthDay ... alley will likely never want to return there, having associated ... neuroscientists working with mice say they,ve discovered the brain circuit ... emotions. And in rodent tests, they,ve manipulated brain cells to ... they made once-reluctant mice want to return to that dark ...
(Date:8/27/2014)... MI (PRWEB) August 27, 2014 Michigan Head ... help the children of a local elementary school by ensuring ... Siersma Elementary School has year-round attendance, and Michigan Head & ... to meet the new school year. , "There are a ... this is a great way to give back to our ...
(Date:8/27/2014)... The federal judge overseeing thousands of ... the deadline for plaintiffs to enroll in the U.S. ... by U.S. District Judge David Katz of the Northern ... DePuy ASR Settlement Program must do so by September ... Implant Products Liability Litigation – MDL 2197) , “Our ...
(Date:8/27/2014)... News) -- Pouring half a glass of wine at a time ... study. Researchers asked 74 college students and staff to pour ... had varying amounts of wine in them. The participants were told ... a "rule of thumb" about how much to pour -- such ... the top -- poured less wine than those without set guidelines. ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:'Half a Glass' Rule May Curb Overdrinking 2
... Center,s Average ER Wait TimePANAMA CITY, Fla., May 21 ... area to find out the average ER wait time at ... The hospital is posting its average ER wait times ... became the only hospital in our area to post our ...
... opened door to NUHW organizing effortOAKLAND, Calif., May 21 ... the recent decision by the California Public Employee Relations ... Medical Center (DMC) in San Pablo to continue. The ... violations of labor law by DMC management and organizers ...
... span in mice may hold hope for people, , , THURSDAY, ... discovered a way to boost chemotherapy and slightly extend the ... for more effective treatments in people. , There,s no guarantee ... it did, the researchers don,t expect that it would add ...
... and Financing Offerings Help Healthcare Providers to Accelerate ... May 21 Perot Systems Corporation (NYSE: ... today announced the availability of financing options to ... implementation of electronic health records which are being ...
... Committee, the region,s most prominent business organization, today applauded ... Board report in Atlanta, Georgia. Greater Baltimore Committee ... Board process has been of great value to the ... is appreciated by the business community. He is ...
... health and economic data like you,ve never seen it ... Hans Rosling will show how reproductive health ... will also illustrate how the convergence of conditions around ... "Western" and "developing" categories an outdated concept.On Tuesday, ...
Cached Medicine News:Health News:ER Wait Times at Your Fingertips 2Health News:Doctors Medical Center Election Tainted 2Health News:A New Way to Get Chemo to Pancreatic Tumors 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 3Health News:Gapminder's Hans Rosling Brings Poverty, Health Data to Life at Wilson Center 2
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
(Date:8/27/2014)... 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... pharmaceutical development, clinical trial manufacturing, and advanced analytical and ... it will participate at the upcoming Rodman & Renshaw ... held in New York . The ... September 9, 2014 at the New York Palace Hotel. ...
(Date:8/27/2014)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... results for its third quarter of fiscal 2014: ... , Revenue of $1,291,378, a 13% decrease over the same ... the quarter of $240,156 compared to net income of $238,826 ... For the nine months ended June 30, 2014: ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... March 8, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... of BioMarin, will present a company update at the Barclays ... at 4:15 p.m. ET.   Interested parties may ... the investor section of the BioMarin website, www.BMRN.com . ...
... (Nasdaq: VRML ) –Vermillion, a molecular ... data from its collaboration with Johns Hopkins University School ... specificity of CA125 for the identification of malignant ovarian ... Meeting on Women,s Cancer of the Society of Gynecologic ...
Cached Medicine Technology:BioMarin to Present at the Barclays Global Healthcare Conference 2Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test 2Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: